BPC 157 and gut-liver-brain healing: Emerging clinical targets
Monitoring Immune Response 2
Regular physical activity and dietary adjustments not only complement the medical weight loss treatment but amplify its metabolism-boosting effects
Morgan James from the University of Sydney (Horizon Fellowship), the National Institute on Drug Abuse (R00 DA04765 and R37 DA061303), the National Heart, Lung, and Blood Institute (U01HL150852), Rutgers Optimizes Innovation, the New Jersey Health Foundation (PC144-23 and PC98-22), and an International Collaborative Research Grant from Rutgers Global
Innovation Awards Evaluation of long-acting kappa opioid receptor antagonism in phase 1 human clinical trial Charles Chavkin, Ph.D., University of Washington Treatment options for persons with severe substance use disorder are limited and relapse during abstinence is common